BRIDGEWAY CAPITAL MANAGEMENT, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$317,940
-44.2%
227,100
-26.6%
0.01%
-42.9%
Q2 2023$569,294
-25.7%
309,399
-1.9%
0.01%
-30.0%
Q1 2023$766,665
+67.2%
315,500
-1.6%
0.02%
+66.7%
Q4 2022$458,601
-35.9%
320,7000.0%0.01%
-36.8%
Q3 2022$715,000
-8.1%
320,700
-14.6%
0.02%
+5.6%
Q2 2022$778,000
-28.6%
375,700
+0.1%
0.02%
-14.3%
Q1 2022$1,089,000
+9.0%
375,400
+20.6%
0.02%
+10.5%
Q4 2021$999,000
+2.1%
311,200
+12.7%
0.02%0.0%
Q3 2021$978,000
+39.5%
276,200
+24.9%
0.02%
+46.2%
Q2 2021$701,000
-21.2%
221,200
-14.5%
0.01%
-23.5%
Q1 2021$890,000
+10.6%
258,700
-19.0%
0.02%0.0%
Q4 2020$805,000
-8.7%
319,400
-23.6%
0.02%
-15.0%
Q3 2020$882,000
+54.5%
418,000
+64.0%
0.02%
+66.7%
Q2 2020$571,000
-39.9%
254,900
-32.1%
0.01%
-45.5%
Q1 2020$950,000
-15.3%
375,500
-11.9%
0.02%
+46.7%
Q4 2019$1,121,000
-26.9%
426,1000.0%0.02%
-28.6%
Q3 2019$1,534,000
+6.5%
426,100
-0.3%
0.02%
+16.7%
Q2 2019$1,440,000
+22.2%
427,400
-1.0%
0.02%
+20.0%
Q1 2019$1,178,000
+156.1%
431,600
+160.6%
0.02%
+150.0%
Q4 2018$460,000
-32.6%
165,6000.0%0.01%
-14.3%
Q3 2018$682,000
+5.1%
165,600
+32.5%
0.01%0.0%
Q2 2018$649,000
-66.7%
125,000
-46.3%
0.01%
-70.8%
Q1 2017$1,948,000
-13.0%
232,700
-27.9%
0.02%
-17.2%
Q4 2016$2,240,000
+55.4%
322,700
+13.9%
0.03%
+38.1%
Q3 2016$1,441,000
-21.7%
283,200
-8.1%
0.02%
-27.6%
Q2 2016$1,840,000
+31.2%
308,2000.0%0.03%
+20.8%
Q1 2016$1,402,000
+1.2%
308,200
+0.2%
0.02%
-7.7%
Q4 2015$1,385,000
+42.1%
307,7000.0%0.03%
+30.0%
Q3 2015$975,000
+17.2%
307,700
+12.0%
0.02%
+25.0%
Q2 2015$832,000
+17.3%
274,700
+14.4%
0.02%
+6.7%
Q1 2015$709,000
-33.7%
240,200
-0.2%
0.02%
-37.5%
Q4 2014$1,069,000
-13.8%
240,700
-0.1%
0.02%
-22.6%
Q3 2014$1,240,000
-1.9%
240,8500.0%0.03%
-6.1%
Q2 2014$1,264,000
+26.5%
240,850
+0.3%
0.03%
+13.8%
Q1 2014$999,000
+42.5%
240,2000.0%0.03%
+38.1%
Q4 2013$701,000
+15.9%
240,2000.0%0.02%0.0%
Q3 2013$605,000
+21.0%
240,2000.0%0.02%
+5.0%
Q2 2013$500,000240,2000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders